TFX announces $2B divestitures, acquires VI Business for $825M, faces activist pressure

Filed May 7, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 1, 2025 · ~2 min read

Key Changes

• high

  Definitive agreements signed to divest Acute Care, Interventional Urology, and OEM businesses for $2.0 billion cash ($1.8B net after-tax), with proceeds earmarked for share buybacks and debt paydown. Transactions expected to close in 2026.

  MD&A: Strategic Divestitures verify on EDGAR →
• high

  Activist investor Irenic Capital Management launched public campaign March 27, 2026 seeking board changes and strategic alternatives review. Company has retained legal, financial, and communications advisors, with costs expected to impact future results.

  Risk Factors: Activist Stockholder Campaign verify on EDGAR →
• high

  Gross margin compressed 560 basis points to 56.1% driven by tariffs enacted in 2025, VI Business acquisition-related inventory and intangible amortization, quality remediation costs, and higher logistics expenses.

  MD&A: Gross Margin verify on EDGAR →